Appointment booking for Dr. Howard Mishoulam, MD is currently not available.Dr. Howard Mishoulam, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Howard Mishoulam, MD (he/him) is a Oncologist in Munster, IN with over 18 years of experience. What is your opinion of Dr. Howard Mishoulam, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Howard Mishoulam, MD has received over $2,269 which includes payments from the following companies:
$578.14 from Celgene Corporation
$380.87 from Novartis Pharmaceuticals Corporation
$240.57 from E.R. Squibb & Sons, L.L.C.
$175.27 from Genentech USA, Inc.
$148.92 from GlaxoSmithKline, LLC.
$128.25 from Amgen Inc.
$123.69 from Alexion Pharmaceuticals, Inc.
$114.17 from LILLY USA, LLC
$61.38 from Eisai Inc.
$47.46 from Prometheus Laboratories Inc.
$40.17 from Medivation Inc.
$38.46 from Merck Sharp & Dohme Corporation
$35.57 from Pfizer Inc.
$34.03 from Janssen Biotech, Inc.
$33.23 from Janssen Pharmaceuticals, Inc
$23.07 from ProStrakan, Inc.
$16.72 from Astellas Pharma US Inc
$14.67 from INSYS Therapeutics Inc
$14.18 from AstraZeneca Pharmaceuticals LP
$10.49 from Daiichi Sankyo Inc.
Payments received by Dr. Howard Mishoulam, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!